Skip to content

Now I have enough information to review the GO-CAM model. Let me provide a comprehensive review:

Review of GO-CAM Model: gomodel:5fadbcf000000868

Basic Information

  • Title: "dUMP catabolic process (Mouse)"
  • Taxon: Mouse (NCBITaxon:10090)
  • Status: Production
  • Model ID: gomodel:5fadbcf000000868

Model Overview

This GO-CAM model represents the dUMP (deoxyuridine monophosphate) catabolic process in mouse. The model describes a pathway with several enzymatic steps involved in the degradation of dUMP, with each activity enabled by a specific gene product.

Model Architecture

The pathway described has the following steps (ordered by the causal flow):

  1. NT5C3 (MGI:MGI:1927186) - 5'-nucleotidase activity (GO:0008253) in cytosol
  2. UPP1 (MGI:MGI:1097668) - deoxyuridine phosphorylase activity (GO:0047847) in cytosol
  3. DPYD (MGI:MGI:2139667) - dihydropyrimidine dehydrogenase (NADP+) activity (GO:0017113) in cytosol
  4. DPYS (MGI:MGI:1928679) - dihydropyrimidinase activity (GO:0004157) in cytosol
  5. UPB1 (MGI:MGI:2143535) - beta-ureidopropionase activity (GO:0003837) in cytosol

Additionally, there are two activities in the model: - NT5C (MGI:MGI:1354954) - 5'-nucleotidase activity (GO:0008253) in cytosol - AGXT2 (MGI:MGI:2146052) - beta-alanine:pyruvate transaminase activity (GO:0016223) in mitochondrion

The model follows a linear flow of causal connections using the "provides input for" (RO:0002413) predicate, showing how each enzymatic reaction in the pathway leads to the next one.

Evidence Assessment

The model uses published scientific literature as evidence for most annotations: - PMID:14154460 - Specificity of mouse uridine phosphorylase - PMID:5472365 - Studies of a mutation affecting pyrimidine degradation in inbred mice - PMID:27062388 - Study on β-alanine transamination enzymes - PMID:10681516 and PMID:6301357 - Studies on 5'-nucleotidase

Evidence codes used are appropriate: - ECO:0000314 (direct assay evidence used in manual assertion) for most activities - ECO:0000266 (sequence orthology evidence used in manual assertion) in some cases

Strengths of the Model

  1. The model clearly represents the enzymatic steps in the dUMP catabolic pathway with appropriate molecular functions.
  2. Each activity is properly connected to the next through causal associations.
  3. Subcellular locations are specified for all activities (most occur in cytosol, with one in mitochondrion).
  4. Evidence is provided for all assertions with appropriate references and evidence codes.
  5. The model captures the biological process correctly, with all activities being part of "dUMP catabolic process" (GO:0046079).

Issues and Recommendations

  1. Parallel Activities: The model includes two 5'-nucleotidase activities (NT5C and NT5C3) that both feed into UPP1. The literature suggests these are distinct isozymes with different substrate specificities, but the model doesn't clearly indicate why there are two parallel inputs to the pathway.

  2. Activity Endpoints: The model includes UPB1 (beta-ureidopropionase) and AGXT2 (beta-alanine:pyruvate transaminase), but AGXT2 isn't causally connected to any other activities. Based on the PMID:27062388 paper, AGXT2 is involved in β-alanine metabolism, which is the product of UPB1. There should be a causal connection between UPB1 and AGXT2 to complete the pathway.

  3. Subcellular Locations: While most activities are correctly located in the cytosol, AGXT2 is shown in the mitochondrion. This is consistent with the literature, but it would be helpful to show how metabolites move between compartments.

  4. Consistency with Complex Guidelines: This model doesn't involve protein complexes, so the complex annotation guidelines don't apply directly. Each activity is represented by a single gene product, which is appropriate when the activities are carried out by monomeric enzymes.

Recommendations for Improvement

  1. Complete the Pathway: Add a causal connection between UPB1 and AGXT2 to show how beta-alanine produced by UPB1 is further metabolized by AGXT2 in the mitochondrion.

  2. Clarify Isozyme Roles: Consider adding annotations to clarify the different roles or preferences of the two 5'-nucleotidases (NT5C and NT5C3) in the pathway based on the detailed isozyme characterization in PMID:6301357.

  3. Transport Between Compartments: Consider adding a transport step to show how beta-alanine moves from the cytosol to the mitochondrion for further metabolism by AGXT2.

Conclusion

Overall, this is a well-constructed GO-CAM model that accurately represents the dUMP catabolic process in mouse. The model follows a logical flow, uses appropriate evidence, and correctly associates gene products with their molecular functions and cellular locations. With minor improvements to connect AGXT2 to the rest of the pathway and clarify the roles of the 5'-nucleotidase isozymes, this model would provide an even clearer representation of the pathway.